Interferon-induced transmembrane 3 (IFITM3) is known to restrict the entry of a range of enveloped viruses. The single nucleotide polymorphism rs12252-C within IFITM3 has been shown to be associated with severe influenza A virus infection. It has been suggested that rs12252-C results in expression of a truncated IFITM3 protein lacking the first 21 amino acids. By performing high-throughput RNA sequencing on primary dendritic cells and peripheral blood mononuclear cells isolated from pandemic H1N1 influenza and human immunodeficiency virus-1 (HIV-1) infected patients we show that full-length IFITM3 mRNA is dominantly expressed (>99%) across all rs12252 genotypes. Full-length IFITM3 protein can be detected in all genotypes.
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Interferon-induced transmembrane protein 3 (IFITM3) has been shown to restrict the replication of influenza A virus (IAV) and other enveloped viruses that enter cells via the endosomal pathway, such as West Nile virus and human immunodeficiency virus (HIV) [1] . The importance of IFITM3 in controlling IAV was highlighted by the work of Everitt et al (2012) [2] who showed that the severity of infection was significantly increased in ifitm3 knockout mice compared to wild type (WT) mice. In addition to their work on ifitm3 knockout mice, Everitt et al [2] also reported that a disproportionately large number of northern European patients hospitalized with severe seasonal or pandemic influenza H1N1/09 virus were carriers of the minor allele of an IFITM3 single-nucleotide polymorphism (SNP), rs12252 (major allele T, minor allele C). The allele frequencies of rs12252 are varied in human populations, with the allele frequency of the C variant being much higher in the Han Chinese population (minor allele frequency [MAF], 0.53) compared to the Northern European population (MAF, 0.034) [3] .
Previously, we were able to confirm an association between rs12252-C and the severity of IAV infection in a large cohort of Chinese patients. In this cohort, 69% of patients with severe pandemic influenza A H1N1/09 virus infection carried the CC genotype, compared to 25% of those with mild infections [3] . In a second study, we observed a significantly higher frequency of the CC and CT genotypes in HIV-1-infected patients who were rapid disease progressors compared to slow disease progressors [4] . This SNP was also shown to be associated with severe avian influenza H7N9 and Hantaan virus infections in Chinese populations [5] [6] [7] ; however, this association was not observed in 2 studies on European cohorts [8, 9] or in a recent American study [10] .
It has been suggested that rs12252-C changes the affinity of a splicing acceptor site in the coding sequence of exon 1 of IFITM3 [2] . This is predicted to result in the expression of alternative IFITM3 mRNA isoforms, (ENST00000602735.2 and ENST00000526811.4) incurred via usage of alternative 5′ untranslated regions upstream of the canonical first exon. These transcripts vary from the canonical transcript (ENST00000399808.4) as they have a 21-amino acid deletion at the N-terminus.
Transfection of truncated IFITM3 into WT cells revealed that this version had a different subcellular distribution in comparison to the full-length protein, potentially explaining the differential viral restriction seen with rs12252 mutations [11] . Additionally, studies have shown that the first 21 amino acids of the N-terminus are required for attenuation of vesicular stomatitis virus replication, and that truncated IFITM3 protein fails to restrict the replication of various strains of influenza virus [2, 3] . The truncated version of IFITM3 has also been shown to have an impact on antiviral activity in HIV-1 infection [12, 13] . Conversely, using native and epitope-tagged IFITM3 isoforms, Williams et al [14] showed that both full-length and truncated IFITM3 restricted entry and replication of H1N1 efficiently. Truncated IFITM3 also had an attenuated yet significant effect on the restriction of H3N2 IAV. Despite the discrepancies, overall this has led to the hypothesis that the observed effects of rs12252-C in patient cohorts are attributable to the alternative splicing of IFITM3 [2] .
However, expression of truncated IFITM3 protein in primary cells carrying the rs12252-C polymorphism has not previously been shown. One of the major obstacles in studying IFITM3 expression was the lack of an IFITM3-specific antibody. Due to high homology between IFITM2 and IFITM3, all commercially available anti-IFITM3 antibodies have high cross-reactivity to IFITM2. To overcome this obstacle, we developed an anti-IFITM3 antibody specific to the first 21 amino acids on the N-terminus of IFITM3, and with a very low cross-reactivity to IFITM2. We then used this antibody to investigate the presence of full-length IFITM3 protein in primary cells with different rs12252 genotypes. Furthermore, in this study we examined the presence of the truncated IFITM3 isoforms in primary dendritic cells (DCs) carrying the rs12252-C allele, and in peripheral blood mononuclear cells (PBMCs) collected from patients infected with either seasonal IAV or HIV-1.
MATERIALS AND METHODS

Ethics Statement
This study was approved by the local ethics committee of Beijing You' An Hospital and the University of Oxford Tropical Ethics Committee (OXTREC 16-10 and 1001-13). All methods were performed in accordance with the relevant guidelines and regulations, and informed consent was obtained from all human subjects.
Study Subjects
Monocyte-derived DCs were isolated from a total of 9 healthy UK volunteers, carrying the TT, CT, or CC genotype. Cells were infected for 10 hours with nonreplicating green florescent protein (GFP)-expressing influenza virus (S-FLU; [15] ) pseudotyped with H7 protein from A/Anhui/1/2013. S-FLU is only capable of 1 round of infection; an eGFP gene replaces segment 4 of the influenza genome (containing the hemagglutinin gene). GFP-positive cells were sorted prior to RNA extraction (RNeasy Plus mini kit, Qiagen). RNA was also isolated from stored PBMC samples collected from acute HIV-1 infected (1-2 months after the diagnosis) and pdmH1N1 infected patients from the Beijing You'an Hospital bio-bank as described in our previous publications [3, 4] .
RNA Sequencing and Analysis
Transcriptome libraries were prepared at the Wellcome Trust Centre for Human Genetics, Oxford University, UK (DCs from healthy volunteers), and the Beijing Genomics Institute (BGI), China (patient PBMCs) using standard protocols (Supplementary material).
IFITM3-Specific Antibody Production and Screening
To produce IFITM3-specific antibodies, mice were immunized with a polypeptide consisting of the first 21 amino acids at the N-terminus of IFITM3. Hybridoma cell lines were generated from the spleen of the immunized mice and screened for anti-IFITM3 antibody production. The binding activity of each antibody to IFITM3 was verified by enzyme-linked immunosorbent assay (ELISA). Binding affinity and cross-reactivity with IFITM2 protein were assessed using inhibition ELISA (further details in Supplementary material).
Generation of IFITM3 Knock Out HEK293T Cell Line
Guide RNAs (gtcaaatcgggatttggccg; ggcctggaagatcagcact) were designed with the MIT CRISPR web tool and cloned into px458 plasmids with a mRuby2 fluorescent protein. HEK293 cells were transfected in bulk with Lipofectamine 2000 (Thermo Fisher Scientific). Single cells were sorted after 48 hours based on presence of mRuby2 signal. Clones were probed with anti-IFITM3 antibody and sequenced at guide loci to confirm knock out of the IFITM3 gene.
Western Blot Analysis of IFITM3 Protein Expression
HEK293T, IFITM3
−/− HEK293T, and fibroblast cell lines were homogenized using RIPA lysis buffer (Thermo Fisher Scientific). Anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody clone 6C5 (Merck Millipore, MAB374) was used as control antibody; our in-house anti-IFITM3 antibody (XA254.3) was compared with commercially available anti-IF-ITM3 antibody (Clone AF311a, VWR). Primary antibodies were probed by IRDye 680LT goat antimouse (Li-Cor, 926-68020) and IRDye 800LT goat antirabbit (Li-Cor, 925-32210), and visualized using the Li-Cor Odyssey Imaging System.
RESULTS
All rs12252 Genotypes Express Full-Length IFITM3 Transcript in H7N1 S-FLU-Infected DCs
To verify the expression of IFITM3 isoforms in all rs12252 genotypes, we performed RNA-Seq analysis on DCs infected with nonreplicating GFP-expressing H7N1 influenza virus (S-FLU). Splicing analysis showed a predominant expression of full-length IFITM3 (ENST00000399808.4) in all 3 genotypes, before and after H7N1 S-FLU infection ( Figure 1A ). In all 3 genotypes, IFITM3 transcript was induced more than 100-fold following S-FLU infection. Furthermore, low-level expression of a transcript predicted to be degraded by nonsense-mediated decay (NMD; ENST00000531688.1) was observed (less than 0.5% of total IFITM3 transcripts). After S-FLU infection, less than 0.005% of total IFITM3 transcript was truncated IFITM3 (missing 21 amino acids on N-terminal; ENST00000602735.2, ENST00000526811.4). More importantly, no significant difference was observed when comparing expression ratios of IFITM3 isoforms across CC and TT rs12252 genotypes. These results indicate full length IFITM3 transcript is dominantly expressed at a similar level in all 3 genotypes.
All rs12252 Genotypes Express Full-Length IFITM3 Transcript in Virus-
Infected PBMCs and Fibroblast Cell Lines
We further investigated the transcript levels of IFITM3 isoforms in PBMCs isolated from HIV-1-positive subjects and individuals infected with pdmH1N1 influenza virus. Similar to our observation in DCs, individuals infected with either virus showed negligible expression of the truncated IFITM3 isoforms. The full-length IFITM3 isoform was found to be dominantly expressed across all 3 genotypes ( Figure 1B and C) , which suggests full-length IFITM3 expression is dominant in all major types of peripheral immune cells, regardless of genotype. Similar results were also found in primary fibroblast cell lines before and following interferon-α (IFN-α) treatment ( Figure 1D ).
Expression of Full-Length IFITM3 Protein was Detected in rs12252 Variants
Using a Novel Antibody Specific to IFITM3 N-Terminus
Because all commercially available IFITM3 reactive monoclonal antibodies cross-react with IFITM2, we developed a highly specific anti-IFITM3 monoclonal antibody targeting the first 21 amino acids on the IFITM3 N-terminus. The calculated half maximum inhibitory concentration (IC 50 ) for this antibody was 1.04 nM, and this antibody showed very low cross-reactivity to IFITM2 in ELISA experiments (cross-reactivity [CR] = 0.00066%; Figure 2A and B).
The specificity of this antibody was further verified by western blot in WT and IFITM3 −/− HEK293T cell lines probed with our in-house IFITM3-specific antibody and an anti-IFITM3 commercial antibody, highly cross-reactive to IFITM2. Our in-house IFITM3-specific antibody detected a single 15-kDa band in WT HEK293T cells and not in the IFITM3 −/− cells. However, using the commercial antibody we could detect a 15-kDa band in both cell lines, although at a lower level in the IFITM3 −/− cell line, as expected ( Figure 2C ). This antibody was next used to measure the presence of full-length IFITM3 protein in fibroblast cell lines from TT and CC patients. Full-length protein was detected in both cell lines ( Figure 2D )
Discussion
Various studies have demonstrated that the C allele of rs12252 is associated with severe IAV infection [2, 3] . To explain this observation, it has been hypothesized that the minor allele rs12252-C results in expression of truncated IFITM3 protein (ie, missing the first 21 amino acids), which is not as effective as full-length IFITM3 in inhibiting the influenza virus [11] . A recent study suggested that the putative rs12252 splice isoform ENST00000526811.4 was not observed in 3 IFITM3 homozygous individuals with pdm2009H1N1 infection [10] . In the current study, we examined this hypothesis by verifying the expression of IFITM3 truncated isoforms (ENST00000602735.2, ENST00000526811.4) in rs12252 genotypes.
We measured the expression of IFITM3 isoforms in DCs before and after infection with nonreplicative H7N1 S-FLU, IFN-α2 stimulated fibroblasts (data not shown), and individuals infected with either HIV-1 or H1N1 virus. High-throughput RNA sequencing showed that a negligible level of truncated IFITM3 mRNA was expressed across all genotypes compared with >99% of the fulllength isoform (ENST00000399808.4). We further showed fulllength protein expression in primary human fibroblasts carrying homozygote rs12252 genotypes. Due to a lack of suitable antibody to the C-terminus of IFITM3 without cross-reactivity to other IFITM proteins, the truncated version of the protein could not be detected by western blot. Because the number of samples was limited, we could not draw any firm conclusions on the differences in full-length protein expression level on the cells carrying different genotypes in our western blot analysis; this merits further investigation.
The results of this study indicate that expression of truncated IFITM3 transcript is negligible, and full-length transcript/protein is dominant in all rs12252 genotypes, making truncated isoforms unlikely to influence viral infections. Our findings do not support the hypothesis that CC genotype carriers express truncated IFITM3 [2] . Although rs12252-C has been consistently associated with IAV, HIV, and Hantaan virus infection in Chinese cohorts, contradictory results have been observed in 2 European cohorts [8, 9] and an American pediatric cohort [10] . This may be due to population bias (ie, low frequency of rs12252-C in European populations); however, it is possible that rs12252 is in linkage disequilibrium with a causative SNP near the IFITM3 locus in Chinese populations. We are currently investigating the functional properties of other closely linked variants that are in linkage disequilibrium with rs12252-C.
Overall, the results of this study showed all rs12252 genotypes dominantly express full-length IFITM3 protein, and a negligible level of truncated transcript, suggesting the truncated isoforms cannot be the underlying explanation for the association between rs12252-C and severe influenza virus infection. Further investigation is required to elucidate the association of rs12252-C with severe viral infection.
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